RH

Rakesh Hasmukhbhai Shah

Active Director Director DIN 02053107
DIN 02053107 First appointment Sep 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Sep 2014
Shareholding value •••• Premium profile

About Rakesh Hasmukhbhai Shah

Data last updated:

Rakesh Hasmukhbhai Shah is a Director at Vadodara Neurological Association (since 2015), Director at Dezai Family Foundation (since 2024) and Director at Avid Superspeciality Hospitals Private Limited (since 2021). The companies operate in Healthcare and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹8.1 Lakh; the largest is Vadodara Neurological Association at ₹4.4 Lakh (FY 2025). Earlier, Rakesh Hasmukhbhai Shah was a Director at Vins Hospital Private Limited (2014–2026) and Director at Vadodara Institute Of Medical Sciences Private Limited (from 2021).

DIN 02053107
Primary Designation Director
Industry Healthcare
First Appointment 17 Sep 2014
Oldest Company Age 19 yrs
Largest company Vadodara Neurological Association · ₹4.4 Lakh (FY 2025)
Combined revenue ₹8.1 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vadodara Neurological Association U85100GJ2015NPL082736
Director27 Mar 20152015₹4.4 Lakh (FY 2025)Active
Dezai Family Foundation U74999GJ2017NPL096429
Director31 Oct 20242017₹3.7 Lakh (FY 2025)Active
Director01 Sep 20212006Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vins Hospital Private Limited U85110GJ2004PTC043583
Director17 Sep 20142004₹16.47 Cr (FY 2024)Active
Director15 Mar 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dezai Family Foundation
Vadodara Neurological Association
Avid Superspeciality Hospitals Private Limited
Vadodara Institute Of Medical Sciences Private Limited
Premium access

Shareholding and investment profile for Rakesh Hasmukhbhai Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Hasmukhbhai Shah

Rakesh Hasmukhbhai Shah currently holds 3 directorships: Vadodara Neurological Association (Director, since 27 Mar 2015, revenue ₹4.4 Lakh (FY 2025)); Dezai Family Foundation (Director, since 31 Oct 2024, revenue ₹3.7 Lakh (FY 2025)); Avid Superspeciality Hospitals Private Limited (Director, since 01 Sep 2021).

Rakesh Hasmukhbhai Shah was first appointed on 17 Sep 2014 as Director at Vins Hospital Private Limited. The most recent appointment on record is 31 Oct 2024 at Dezai Family Foundation.

The 2 current companies of Rakesh Hasmukhbhai Shah that report revenue have a combined latest revenue of ₹8.1 Lakh: Vadodara Neurological Association ₹4.4 Lakh (FY 2025); Dezai Family Foundation ₹3.7 Lakh (FY 2025).

Rakesh Hasmukhbhai Shah held 2 earlier board appointments: Vins Hospital Private Limited (Director, 17 Sep 2014 to 06 Feb 2026); Vadodara Institute Of Medical Sciences Private Limited (Director, from 15 Mar 2021).

The current boards of Rakesh Hasmukhbhai Shah's companies include Amit Pravinchandra Shah (Vadodara Neurological Association), Apeksh Krushnakant Patwa (Vadodara Neurological Association), Bhadresh Kumar M Patel (Vadodara Neurological Association), Gopal Satishchandra Parikh (Vadodara Neurological Association), Suresh Radhakrishna Nayak (Vadodara Neurological Association), Mehul Dilip Desai (Dezai Family Foundation), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available